Clinical Trial

The Postoperative Radiotherapy in N1 Breast Cancer Patients

Study acronym: PORT-N1
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study is a multicenter, randomized, phase 3 clinical trial in patients with breast cancer, randomizing radiotherapy group (postmastectomy radiation therapy (PMRT)/whole breast irradiation plus regional radiotherapy (WBI+regional RT) versus and no PMRT/WBI alone group. This is a non-inferiority study aiming that there is no significant difference in the 7-year disease-free survival rate between the two groups.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-06-27; most recent amendment 2024-11-26.
Status change: Not Yet Recruiting → Recruiting 2022-08-28
Trial Details
NCT Number NCT05440149
Lead Sponsor Seoul National University Hospital
Conditions Radiotherapy, Breast Cancer
Enrollment 1,106 participants
Start Date 2022-08-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2033-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-29